AC
RNAM

Armistice Capital’s Avidity Biosciences RNAM Stock Holding History

Armistice Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,159
Closed -$300K – 419
2025
Q4 		$300K Buy
+4,159
New +$269K ﹤0.01% 250

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Armistice Capital's RNAM Position: Q1 2026 in Review

Armistice Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,159 shares — an estimated $300K sold.

Armistice Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $300K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Armistice Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Armistice Capital sold 4,159 Avidity Biosciences shares in Q1 2026, an estimated $300K.
  • Armistice Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Armistice Capital's Avidity Biosciences position peaked at $300K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.